Targeting
Contributors of aging, degeneration, metabolic dysfunction, and inflammation
Sironax is committed to bringing new treatments to patients by targeting the underlying contributors of degeneration — including disrupted energy homeostatis, dysregulated cell death, and uncontrolled inflammation — across various organs and tissues.
